Characteristic | Value* | Missing data† | Characteristic | Value* | Missing data† |
Age, years | 73 (66, 81) | 0 (0.0%) | Vascular access | 44 (8.7%) | |
Female sex | 185 (36.5%) | 0 (0.0%) | AV fistula | 375 (74.0%) | |
Dialysis vintage, months | 61 (23, 117) | 25 (4.9%) | AV graft | 59 (11.6%) | |
Cause of ESRD | 14 (2.8%) | Superficial artery | 17 (3.4%) | ||
Diabetic nephropathy | 203 (40.0%) | Permanent catheter | 12 (2.4%) | ||
Nephrosclerosis | 100 (19.7%) | History of bacteraemia | 50 (9.9%) | 4 (0.8%) | |
Glomerulonephritis | 87 (17.2%) | Medication | |||
Other/unknown | 103 (20.3%) | Steroids | 50 (9.9%) | 3 (0.6%) | |
Vital signs | Immunosuppressants | 7 (1.4%) | |||
Body temperature, °C | 37.1 (36.6, 38.0) | 36 (7.1%) | Antibiotics within 1 week | 83 (16.4%) | 6 (1.2%) |
Systolic BP, mm Hg | 136 (113, 159) | 30 (5.9%) | Laboratory findings | ||
Systolic hypotension‡ | 71 (14.0%) | 30 (5.9%) | White cell count, 10 9/L | 7.9(5.7, 11.2) | 12 (2.4%) |
Respiratory rate, breaths/min | 20 (16, 24) | 255 (50.3%) | Platelet count, 10 9/L | 153 (107, 209) | 12 (2.4%) |
Tachypnea§ | 89 (17.6%) | 255 (50.3%) | Albumin, g/dL | 3.3 (2.9, 3.7) | 53 (10.5%) |
Heart rate, beats/min | 86 (75, 100) | 35 (6.9%) | C reactive protein, mg/dL | 5.9 (1.7, 12.6) | 18 (3.6%) |
SpO2, % | 97 (95, 100) | 118 (23.3%) | |||
GCS score <13 | 46 (9.1%) | 80 (15.8%) | Positive blood culture | 68 (13.4%) | 0 (0.0%) |
Comorbidities | In-hospital death | 74 (14.6%) | 0 (0.0%) | ||
Malignancy | 61 (12.0%) | 1 (0.2%) | |||
Diabetes | 222 (43.8%) | 1 (0.2%) |
↵*Continuous data are summarised as median (IQR), while categorical data are summarised as frequency and percentage.
↵†Missing data are summarised as frequency and percentage.
↵‡Systolic hypotension was defined as systolic BP ≤100 mm Hg.
↵§Tachypnea was defined as a respiratory rate of ≥22 breaths/min.
AV, arteriovenous; BP, blood pressure; ESRD, end-stage renal disease; GCS, Glasgow Coma Scale